Picture of Basilea Pharmaceutica AG Allschwil logo

BSLN Basilea Pharmaceutica AG Allschwil Cashflow Statement

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Basilea Pharmaceutica AG Allschwil, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-22.4-14.7-6.8312.110.5
Depreciation
Non-Cash Items3.81-9.845.844.096.21
Unusual Items
Other Non-Cash Items
Changes in Working Capital-46.9-30.8-31.8-10.3-3.99
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-63.8-54.1-327.0614.2
Capital Expenditures-0.404-2.27-0.86-3.3-1.03
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0-32.74.43950
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.404-353.5891.6-1.03
Financing Cash Flow Items-3.19
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.3145.116.6-45.2-57.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-62.9-44.8-11.353.6-44.2